Cultures Technology Maintains Pizza Cheese Batch-to-Batch
Dupont Nutrition & Health says its technology can improve yield and decrease time in production.
Dupont Nutrition & Health (Copenhagen) has brought to market a cultures series that the company says will improve pizza cheese quality, batch-to-batch. Called Choozit Swift, the Streptococcus thermophilus cultures series uses CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Technology. The technology reportedly gives cultures a built-in immunity to phages that would normally trouble cheese production.
“Achieving consistency and reliability is a major hurdle for pizza cheese manufacturers,” says Annie Mornet, global business director for Choozit. “Every gram of fat or protein and every minute lost during processing have an impact on performance…By optimizing phage control and acidification, manufacturers will experience a positive effect on yield and shelf life.”
Dupont says its culture series can improve pizza cheese yield, optimize time, and minimize product downgrades.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
The 2023 Supplement Consumer: Immune Health and Beyond
April 19th 2024Did you know two-out-of-three U.S. supplement consumers say their immune health has become more important to them, yet only 38% would describe their immune health as “very healthy?” There’s an opportunity to meet consumers in their growing desire to live healthier lifestyles and help them redefine resilience. IMMUSETM is the universal postbiotic for year-round immune support. Unlock exclusive consumer insights and discover the formulation opportunities with IMMUSETM with this consumer research.
